相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Osimertinib for EGFR T790M mutation-positive non-small cell lung cancer
Kenzo Soejima et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2017)
Shikonin induces necroptosis by reactive oxygen species activation in nasopharyngeal carcinoma cell line CNE-2Z
Zixuan Zhang et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2017)
Iron Oxide Nanoparticles Synergize with Erlotinib to Suppress Refractory Non-Small Cell Lung Cancer Cell Proliferation Through the Inhibition of ErbB/PI3K/AKT and PTEN Activation
Meili Zhang et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2017)
Epidermal Growth Factor Receptor Tyrosine Kinase: A Potential Target in Treatment of Non-Small-Cell Lung Carcinoma
V. Vinod Prabhu et al.
JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY (2017)
Successful AZD9291 Therapy in Advanced Non–Small Cell Lung Cancer after Failure of HM61713
Chien-Wei Chen et al.
Journal of Thoracic Oncology (2017)
Osimertinib induces autophagy and apoptosis via reactive oxygen species generation in non-small cell lung cancer cells
Zheng-Hai Tang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
Osimertinib (AZD9291) decreases programmed death ligand-1 in EGFR-mutated non-small cell lung cancer cells
Xiao-Ming Jiang et al.
ACTA PHARMACOLOGICA SINICA (2017)
Synergistic antitumor effect of 3-bromopyruvate and 5-fluorouracil against human colorectal cancer through cell cycle arrest and induction of apoptosis
Dianlong Chong et al.
ANTI-CANCER DRUGS (2017)
The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613
Jordi Remon et al.
CLINICAL LUNG CANCER (2017)
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Daniel J. Klionsky et al.
AUTOPHAGY (2016)
Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity
Peter Ballard et al.
CLINICAL CANCER RESEARCH (2016)
Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
Don S. Dizon et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cells
Zhirui Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer
Shuhang Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
L718Q Mutation as New Mechanism of Acquired Resistance to AZD9291 in EGFR-Mutated NSCLC
Melissa Bersanelli et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Osimertinib in the treatment of patients with epidermal growth factor receptor T790M mutation-positive metastatic non-small cell lung cancer: clinical trial evidence and experience
Ivana Sullivan et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2016)
Third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in T790M-positive non-small cell lung cancer: review on emerged mechanisms of resistance
Roberta Minari et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
EGFR-independent autophagy induction with gefitinib and enhancement of its cytotoxic effect by targeting autophagy with clarithromycin in non-small cell lung cancer cells
Shohei Sugita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Mechanisms underlying 3-bromopyruvate-induced cell death in colon cancer
Yiming Sun et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2015)
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M
Kenneth S. Thress et al.
NATURE MEDICINE (2015)
AZD9291 in EGFR Inhibitor-Resistant Non-Small-Cell Lung Cancer
Pasi A. Jaenne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Autophagy contributes to gefitinib-induced glioma cell growth inhibition
Cheng-Yi Chang et al.
EXPERIMENTAL CELL RESEARCH (2014)
The PI3k inhibitors: new hopes in the battle against advanced NSCLC
Paola Claudia Sacco et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2014)
PIK3CA Mutations Frequently Coexist with EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup
Lei Wang et al.
PLOS ONE (2014)
Autophagosome-Mediated EGFR Down-Regulation Induced by the CK2 Inhibitor Enhances the Efficacy of EGFR-TKI on EGFR-Mutant Lung Cancer Cells with Resistance by T790M (Publication with Expression of Concern. See vol. 14, 2019)
Kwang Sup So et al.
PLOS ONE (2014)
AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
Darren A. E. Cross et al.
CANCER DISCOVERY (2014)
Review of EGFR TKls in etastatic NSCLC, including ongoing trials
Barbara Melosky
FRONTIERS IN ONCOLOGY (2014)
Cotargeting EGFR and autophagy signaling: A novel therapeutic strategy for non-small-cell lung cancer
Xinbing Sui et al.
MOLECULAR AND CLINICAL ONCOLOGY (2014)
EGFR-Mediated Beclin 1 Phosphorylation in Autophagy Suppression, Tumor Progression, and Tumor Chemoresistance
Yongjie Wei et al.
CELL (2013)
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Resistant Disease
Kadoaki Ohashi et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Structure- and Reactivity-Based Development of Covalent Inhibitors of the Activating and Gatekeeper Mutant Forms of the Epidermal Growth Factor Receptor (EGFR)
Richard A. Ward et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer
Yuan-yuan Li et al.
LUNG CANCER (2013)
Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer
Wieslawa H. Dragowska et al.
PLOS ONE (2013)
EGFR Tyrosine Kinase Inhibitors Activate Autophagy as a Cytoprotective Response in Human Lung Cancer Cells
Weidong Han et al.
PLOS ONE (2011)
The PI3-K/AKT-Pathway and Radiation Resistance Mechanisms in Non-small Cell Lung Cancer
Olga C. J. Schuurbiers et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3
Shunsuke Kimura et al.
AUTOPHAGY (2007)
EGFR and HER2 gene copy number and response to first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)
Federico Cappuzzo et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: Implications for cancer therapy
Elizabeth S. Henson et al.
CELLULAR SIGNALLING (2006)
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
H Shigematsu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
分享论文
